 |
answer text |
<p>National Health Service clinical commissioners have promoted national guidance
through their bulletins with clinical commissioning groups members. National guidance
recommends that in circumstances where levothyroxine has failed, endocrinologists
providing NHS services may recommend liothyronine for individual patients after a
carefully audited trial of liothyronine for at least three months duration.</p><p>We
have made no assessment on whether liothyronine should be de-classified as a high
cost medicine. To date, NHS England NHS Improvement have not conducted any specific
assessments on liothyronine following the Competition and Markets Authority ruling.
This will be considered as part of any formal review to national guidance.</p>
|
 |
